Deng, Xinxian <br/><br/>
Drug discovery approaches targeting the incretin pathway.  [electronic resource] 

 -  Bioorganic chemistry  06 2020 
 - 103810 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1090-2120 
<br/><br/><label>Standard No.: </label>10.1016/j.bioorg.2020.103810  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Diabetes Mellitus, Type 2--drug therapy<br/>Dipeptidyl Peptidase 4--metabolism<br/>Dipeptidyl-Peptidase IV Inhibitors--chemistry<br/>Drug Discovery<br/>Glucagon-Like Peptide-1 Receptor--metabolism<br/>Humans<br/>Hypoglycemic Agents--chemistry<br/>Incretins--antagonists & inhibitors<br/>Models, Molecular<br/>Peptides--chemistry<br/>Glucagon-Like Peptide-1 Receptor Agonists